• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYSB2400236 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2024-09-13 Zhuhai United Laboratories Co Ltd view
CYSB2400237 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2024-09-13 Zhuhai United Laboratories Co Ltd view
JYSZ2400051 甘精胰岛素注射液 insulin glargine Injection Biological Products License Renew 2024-09-04 view
CYSB2400224 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2024-08-29 Gan & Lee Pharmaceuticals view
CYSB2400146 甘精胰岛素注射液 insulin glargine Injection Biological Products(3.3) Supplementary Application 2024-06-06 Yichang HEC Changjiang Pharmaceutical Co Ltd view
CYSB2400140 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2024-06-01 Gan & Lee Pharmaceuticals view
CYSB2400141 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2024-06-01 Gan & Lee Pharmaceuticals view
CYSB2400113 甘精胰岛素注射液 insulin glargine Injection Biological Products(3.3) Supplementary Application 2024-05-14 Wanbang Biopharmaceuticals view
JYSB2400080 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2024-04-08 view
JYSB2400079 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2024-04-08 view
CYSB2400040 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2024-02-09 Gan & Lee Pharmaceuticals view
CYSB2400041 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2024-02-09 Gan & Lee Pharmaceuticals view
CYSB2300212 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2023-11-22 Sanofi (Beijing) Pharmaceuticals Co Ltd view
CYSB2300211 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2023-11-22 Sanofi (Beijing) Pharmaceuticals Co Ltd view
CYSB2300190 甘精胰岛素注射液 insulin glargine Injection Biological Products(3.3) Supplementary Application 2023-10-26 Wanbang Biopharmaceuticals view
CYSB2300082 甘精胰岛素注射液 insulin glargine Injection Biological Products(3.4) Supplementary Application 2023-04-13 Shandong New Time Pharmaceutical Co Ltd view
CYSB2300078 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2023-04-05 Gan & Lee Pharmaceuticals view
CYSB2300079 甘精胰岛素注射液 insulin glargine Injection Biological Products Supplementary Application 2023-04-05 Gan & Lee Pharmaceuticals view
JYSZ2300012 甘精胰岛素注射液 insulin glargine Injection Biological Products License Renew 2023-02-28 view
JYSZ2300013 甘精胰岛素注射液 insulin glargine Injection Biological Products License Renew 2023-02-28 view